News on this topic
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head': Pfizer Inc (PFE.N) Chief Executive Albert Bourla called U.S. plans to negotiate drug ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-pouring-covid-profits-into-cancer-battle-ceo-bourla-says-2023-05-11/
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
cnbc.com/2023/05/11/pfizer-medicare-could-face-legal-action-over-drug-price-negotiations.html
More news on this subject
Previous
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head': Pfizer Inc (PFE.N) Chief Executive Albert Bourla called U.S. plans to negotiate drug ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-pouring-covid-profits-into-cancer-battle-ceo-bourla-says-2023-05-11/
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
cnbc.com/2023/05/11/pfizer-medicare-could-face-legal-action-over-drug-price-negotiations.html
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'
rappler.com/business/pfizer-ceo-albert-bourla-reaction-united-states-drug-pricing-reform/
TODAY: Join us for a Reuters Newsmaker with Pfizer CEO Albert Bourla, in conversation with @Reuters Editor-in-Chief Alessandra Galloni at 12:30 p.m. EDT/5:30 p.m ... Show more
Reuters Newsmaker Interview with Albert Bourla: Reuters Newsmaker Interview with Albert Bourla - - Thursday, May 11, 2023
events.reutersevents.com/reuters/newsmaker/albertbourla
SCOTUS mifepristone case: Justices focus on anti-abortion groups’ legal standing: The case has big implications for women's health and the authority of the ...
arstechnica.com/science/2024/03/abortion-pill-case-scotus-skeptical-of-anti-abortion-groups-legal-standing/
Quick Glance: The Significance of the Supreme Court Mifepristone Case
- On June 24, 2022, the constitutional jurisprudence on abortions was overturned by the Supreme Court.
- A pivotal aspect in the dispute FDA v. Alliance for Hippocratic Medicine revolves around making access to medication abortions more challenging.
- The decision could impact not only abortion access but also have implications for miscarriage treatment.
- There are also repercussions for the entire country, voters' preferences in blue states, and state sovereignty.
Exclusive: US lawmaker seeks answers on FDA inspection of Musk's Neuralink: A U.S. lawmaker involved in health policy has asked the Food and Drug Administration ...
reut.rs/3TQQDVp
Quick Glance: Neuralink patient controls 'Mario Kart' with mind
- A video from Neuralink demonstrates the first human patient using his brain-chip implant to play 'Mario Kart.'
- In a gathering with Neuralink employees, the first patient, Noland Arbaugh, was introduced to explain the capabilities of the brain chip.
- Arbaugh, a quadriplegic due to a swimming accident, highlighted how the device enables him to engage in activities like gaming.
- Since the revelation of the first human patient, Arbaugh has showcased tasks achievable with his new brain implant, from gaming late into the night to sharing content on X.
Astra, Pfizer Boost China Bets Despite US Drive to Decouple: The chief executive officers of AstraZeneca Plc and Pfizer Inc. pledged to support expansion of ...
bloomberg.com/news/articles/2024-03-26/astra-pfizer-double-down-on-china-investment-amid-us-tensions
Paid articlePaid
Fears grow over Comstock Act, Justices Thomas, Alito: Abortion rights supporters are sounding the alarm that conservative Supreme Court justices want to use a ...
thehill.com/policy/healthcare/4560476-fears-grow-over-comstock-act-justices-thomas-alito/
US FDA approves Merck's therapy for rare lung condition: The U.S. Food and Drug Administration on Tuesday approved Merck's treatment for adults with high blood ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-mercks-blood-pressure-therapy-2024-03-26/
FDA OKs New Treatment to Prevent COVID in High-Risk People: A new antibody treatment has been approved to help prevent COVID-19, and it will be available in a ...
webmd.com/covid/news/20240326/fda-oks-new-treatment-to-prevent-covid-high-risk-people
Quick Glance: FDA Grants Approval for New Treatment to Prevent COVID in High-Risk Individuals
- A newly approved antibody therapy aims to prevent COVID-19 in individuals who are particularly vulnerable.
- Known as Pemgarda, the monoclonal antibody inhibits the virus from binding to human cells and is administered intravenously.
- Close monitoring is required post-antibody treatment due to severe allergic reactions experienced by some individuals.
- Studies indicate that individuals with weakened immune systems continue to face an increased risk of severe COVID outcomes despite multiple COVID vaccinations.
U.S. FDA approves Akebia's anemia drug: The U.S. Food and Drug Administration approved Akebia Therapeutics' drug, vadadustat, to treat anemia caused by chronic ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-akebias-anemia-drug-2024-03-28/
FDA Opens the Door to Clinical Use of LSD: Studies show benefits for people with high anxiety, depression, and PTSD, but there are questions about how these ...
webmd.com/mental-health/news/20240326/fda-opens-the-door-clinical-use-lsd
SARMs: What’s the Harm?: SARMs alter your hormones to build muscle. They’ve been shown to have similar effects and risks to anabolic steroids and aren’t approved ...
health.clevelandclinic.org/sarms-harmful-side-effects-and-risks
FDA proposes to ban certain shock devices for the second time: The U.S. Food and Drug Administration said on Monday it has proposed a ban of electrical ...
reuters.com/business/healthcare-pharmaceuticals/fda-proposes-ban-certain-shock-devices-second-time-2024-03-25/
Ketanji Brown Jackson Dunks on Alito During Abortion Hearing: He wanted to know if the FDA was infallible. She wondered the same about judges.
thedailybeast.com/ketanji-brown-jackson-dunks-on-alito-during-abortion-hearing
Paid articlePaid
F.D.A. Authorizes a New Covid Drug to Protect High-Risk People: Pemgarda, available in the coming weeks, is intended for immunocompromised people who are ...
nytimes.com/2024/03/25/well/fda-covid-medicine-immunocompromised.html
Elon Musk Takes Ketamine to Help Treat Depression: Does It Work?: In a recent interview, Elon Musk revealed he takes ketamine to help boost his mental health and ...
healthline.com/health-news/elon-musk-ketamine-depression-treatment
Mifepristone access is coming before the US Supreme Court. How safe is this abortion pill?
apnews.com/article/mifepristone-abortion-pill-supreme-court-1d2221251197a391c9bca833918e4554
Tick-killing pill shows promising results in human trial: Should it pan out, the pill would be a new weapon against Lyme disease.
wired.com/story/pill-kills-ticks-lyme-disease-babesiosis-anaplasmosis/
Quick Glance: New Tick-Killing Pill: Hope Against Lyme Disease
- Tarsus Pharmaceuticals is developing a pill for humans that paralyzes and kills ticks to protect against Lyme disease.
- The pill has shown promising results in a small trial, killing ticks within 24 hours of drug intake and lasting effects for up to 30 days.
- The development of this pill could not only protect against Lyme disease but also other tick-borne diseases like babesiosis and anaplasmosis.
- While the efficacy of the pill in preventing Lyme disease is yet to be proven, cautious optimism surrounds its potential as a preventive measure for individuals in tick-infested areas.
Pfizer (PFE) Plans to Sell About £2 Billion of Shares in Haleon (HLN): Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc ...
bloomberg.com/news/articles/2024-03-18/pfizer-plans-to-sell-about-2-billion-of-shares-in-haleon
Paid articlePaid
After earnings plunge, BioNTech pins hopes on cancer drug launches: Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during ...
reuters.com/business/healthcare-pharmaceuticals/after-earnings-plunge-biontech-pins-hopes-cancer-drug-launches-2024-03-20/
Quick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns
seekingalpha.com/article/4678774-pfizer-attractive-valuation-and-a-strong-pipeline-mitigate-patent-cliff-concerns
Paid articlePaid
The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD), an inherited muscle-wasting disorder ... Show more
Pfizer Is Selling a Chunk of Its Haleon Stock. It’s a $3 Billion Windfall.: The sale comes as Pfizer’s need for cash has increased. It recently closed on its $43 ...
on.barrons.com/3II1UkH
US FDA classifies recall of Vyaire Medical's respiratory devices as most serious: The U.S. Food and Drug Administration on Thursday classified the recall of ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-classifies-recall-vyaire-medicals-respiratory-devices-most-serious-2024-03-21/
A Psychedelics Reporter With a Changing Perspective: Can an experimental drug cure opioid addiction? Andrew Jacobs, who writes about psychedelic medicine for The ...
nytimes.com/2024/03/20/insider/psychedelic-ibogaine.html
US FDA approves first drug for fatty liver disease NASH: The U.S. FDA has approved Madrigal Pharmaceuticals' drug for a fatty liver disease known as ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-drug-fatty-liver-disease-nash-2024-03-14/
Quick Glance: First Drug Approval for Fatty Liver Disease NASH by US FDA
- The US FDA has approved Madrigal Pharmaceuticals' drug for the fatty liver disease NASH.
- NASH, now known as metabolic dysfunction-associated steatohepatitis (MASH), affects about 1.5 million Americans.
- The drug will be available in April and is seen as a pivotal moment for patients.
- Other companies are also conducting trials of their drugs for NASH to meet the much-needed treatment.
Experts Warn of Toxins in GM Corn Amid US-Mexico Trade Dispute: "The Mexican government is both wise and on solid ground in refusing to allow its people to ...
commondreams.org/news/genetically-modified-corn
FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice
cnn.com/2024/03/27/health/fda-ivermectin-lawsuit/
Paid articlePaid
Lifesaving gene therapy for kids is world’s priciest drug at $4.25M: It's unclear if government and private insurance plans can cover the costs.
arstechnica.com/science/2024/03/lifesaving-gene-therapy-for-kids-is-worlds-priciest-drug-at-4-25m/
FDA's graphic warning labels for cigarettes are constitutional, US appeals court rules
reuters.com/legal/fda-cigarette-warning-labels-satisfy-first-amendment-us-appeals-court-rules-2024-03-21/
US FDA grants full approval to AbbVie's ovarian cancer therapy: The U.S. Food and Drug Administration said on Friday it had granted traditional approval for ...
reut.rs/496Piyi
First over-the-counter birth control pill now for sale online: Opill, an over-the-counter birth control pill, goes on sale online today. The pill is expected to ...
npr.org/sections/health-shots/2024/03/04/1235404522/opill-over-counter-birth-control-pill-contraceptive-shop
Seelos Therapeutics' ALS treatment fails mid-stage study: Seelos Therapeutics' experimental ALS drug did not meet the main goal of a mid-stage trial ...
reuters.com/business/healthcare-pharmaceuticals/seelos-says-als-treatment-fails-mid-stage-study-2024-03-19/
Currys Lifts Profit Outlook After Bidders Walk Away: Get briefed ahead of your morning calls with the latest UK business headlines, key data and market reaction
bloomberg.com/news/newsletters/2024-03-18/currys-lifts-profit-outlook-after-bidders-walk-away-ltwoi347
Wegovy is now covered by Medicare, but not for weight loss | Here & Now: Wegovy will be covered to prevent heart problems in people with obesity and heart ...
wbur.org/hereandnow/2024/03/26/wegovy-medicare-weight-loss
Hiltzik: The FDA and a bogus COVID treatment : Three right-wing doctors said the FDA's advice against taking ivermectin for COVID infringed on their rights ...
latimes.com/business/story/2024-03-26/column-the-fda-shoots-itself-in-the-foot-by-settling-a-dumb-lawsuit-over-ivermectin
US FDA panel votes in favor of expanded use of Bristol Myers' CAR-T therapy: Advisers to the U.S. Food and Drug Administration on Friday voted in favor of ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-favor-expanded-use-bristol-myers-car-t-therapy-2024-03-15/
US FDA approves BeiGene's esophageal cancer therapy: The U.S. Food and Drug Administration said it has approved BeiGene's drug to treat a type of advanced ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-beigenes-esophageal-cancer-therapy-2024-03-14/
Elon Musk says ketamine can get you out of a 'negative frame of mind'. What does the research say?
abc.net.au/news/2024-03-23/elon-musk-ketamine-negative-state-of-mind-research-say/103619394
Wegovy to be covered by US Medicare for heart disease patients: Heart patients insured under the U.S. Medicare program would be covered for Novo Nordisk's ...
reuters.com/business/healthcare-pharmaceuticals/wegovy-be-covered-by-us-medicare-heart-disease-patients-2024-03-21/
FDA authorizes drug to boost COVID protection for immunocompromised patients: It will offer added protection to high-risk patients who may have weaker responses ...
axios.com/2024/03/25/covid-antibody-fda
In Early Study, People on Weight Loss Pill Lost 13% of Their Body Weight: Novo Nordisk is testing a new weight-loss pill, called amycretin, that is said to lead ...
healthline.com/health-news/in-early-study-people-on-weight-loss-pill-lost-13-of-their-body-weight
Companies Can Claim Yogurt Reduces Diabetes Risk, FDA Says: Yogurt manufacturers can now claim that eating yogurt reduces a person’s risk of type 2 diabetes ...
webmd.com/diabetes/news/20240304/companies-can-claim-yogurt-reduces-diabetes-risk-fda-says
Trader Joe's nut recall: Select lots of cashews recalled for potential salmonella risk
usatoday.com/story/money/food/2024/03/18/salmonella-detected-in-cashews-sold-at-trader-joes/73022841007/
Madrigal Pharma surges after drug wins first approval for fatty liver disease NASH
reuters.com/business/healthcare-pharmaceuticals/madrigal-pharma-surges-fda-nod-first-drug-fatty-liver-disease-nash-2024-03-15/
No End in Sight for National ADHD Drug Shortage: Nearly 18 months after the FDA first acknowledged a national shortage of Adderall, there is now a widespread ...
webmd.com/add-adhd/news/20240312/cm/national-adhd-drug-shortage-continues
FDA Issues New Guidance for Early Alzheimer's Drug Development: The FDA embraces the use of biomarkers and surrogate endpoints in its most recent guidance on ...
medscape.com/viewarticle/fda-issues-new-guidance-early-alzheimers-drug-development-2024a100052v
Paid articlePaid
FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’
cnn.com/2024/03/26/health/winrevair-pah-drug-approval/
Paid articlePaid
Reproductive rights before Supreme Court again with abortion pill access at stake
pbs.org/newshour/show/reproductive-rights-before-supreme-court-again-with-abortion-pill-access-at-stake
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
Medicare spending on Ozempic and similar diabetes drugs soars, study finds, and it could end up costing seniors
cnn.com/2024/03/26/health/medicare-ozempic-diabetes-drugs-spending/
U.S. abortions reach recent high, with record number done via medication: The increase comes as the U.S. Supreme Court is considering whether to limit access to ...
washingtonpost.com/politics/2024/03/19/abortion-medication-mifepristone-63-percent/
Why 2024 may be the most consequential election for reproductive rights in 50 years
pbs.org/newshour/show/why-2024-may-be-the-most-consequential-election-for-reproductive-rights-in-50-years
6.9 million Americans have Alzheimer's disease: How to reduce your risk: Public and private spending to take care of Alzheimer's and dementia patients will ...
usatoday.com/story/news/health/2024/03/20/alzheimers-association-disease-report/72963017007/
US FDA declines to approve Viatris's injection for multiple sclerosis: The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-viatriss-injection-multiple-sclerosis-2024-03-11/
A Psychedelics Reporter With a Changing Perspective: Can an experimental drug cure opioid addiction? Andrew Jacobs, who writes about psychedelic medicine for The ...
nytimes.com/2024/03/20/insider/psychedelic-ibogaine.html
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
reuters.com/business/healthcare-pharmaceuticals/lilly-weight-loss-drug-zepbound-new-us-prescriptions-surpass-wegovy-first-time-2024-03-15/
Biden administration announces focus on ‘flooding the zone’ with life-saving overdose reversal medicine
cnn.com/2024/03/13/health/biden-administration-naloxone/
Paid articlePaid
Madrigal's drug wins first US approval for fatty liver disease NASH as rivals circle
reuters.com/business/healthcare-pharmaceuticals/madrigals-drug-wins-first-us-approval-fatty-liver-disease-nash-rivals-circle-2024-03-14/
US FDA approves expanded use of Mirum's liver disease drug: The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals' oral ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-expanded-use-mirums-liver-disease-drug-2024-03-13/
Becton Dickinson ramps up syringe production in US amid China quality concerns: Becton Dickinson said on Thursday it has increased production of medical syringes ...
reuters.com/business/healthcare-pharmaceuticals/becton-dickinson-increase-domestic-production-syringes-2024-03-21/
Spotlight On: Major Depressive Disorder: The most important news, trends, and treatments that affect people with major depression.
webmd.com/depression/features/cm/mdd-spotlight-on
Apple’s AirPods Pro could be getting a “hearing aid mode” later this year: In development for some time, AirPods could finally get the FDA label this fall.
arstechnica.com/gadgets/2024/03/apples-airpods-pro-could-be-getting-a-hearing-aid-mode-later-this-year/
Manchin says Biden’s reelection is in jeopardy: At POLITICO’s Health Care Summit, the West Virginia Democrat took aim at the president on fentanyl overdoses and ...
politico.com/news/2024/03/13/manchin-biden-reelection-jeopardy-00146763
US FDA approves Novo Nordisk drug Wegovy for use in lowering heart attack risks
reut.rs/48KYDvt
Quick Glance: New Novo Obesity Drug Outperforms Wegovy in Early Trial
- Novo Nordisk announced that initial test results for the experimental obesity drug Amycretin showed a higher weight loss compared to the popular treatment Wegovy.
- Investors reacted positively to the announcement, suggesting Novo has promising products in the pipeline beyond Wegovy's success.
- Following the announcement, Novo's stocks rose by 5.1% to achieve a new all-time high. Nearly half of Novo's current valuation is attributed to the company's pipeline of new experimental drugs like Amycretin.
- Novo also disclosed plans to expand its focus to include treatments for cardiovascular diseases in addition to diabetes and weight loss therapies.
AbbVie to bolster immunity illness drug pipeline with Landos deal: AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker ...
reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-landos-expand-pipeline-immunity-related-illnesses-2024-03-25/
US FDA staff raise concerns over data from J&J, Bristol's CAR-T therapies: The U.S. Food and Drug Administration's staff on Wednesday raised concerns that it was ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flag-safety-concerns-jj-bristols-car-t-therapies-2024-03-13/
Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
apnews.com/article/wegovy-semaglutide-heart-attack-stroke-fda-label-ccbc1fc44ee43f8536596d5f7bbd6876
Quick Glance: US FDA Approves Novo Nordisk's Wegovy for Lowering Heart Risks
- The U.S. FDA approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of stroke and heart attack in overweight or obese adults without diabetes.
- Novo's GLP-1 drugs are widely used, and the FDA approval for heart benefits is expected to increase their usage.
- The FDA's approval of new cardiovascular indications may encourage employers and insurers to provide coverage for the drug despite its high cost.
- Novo has applied to add Wegovy's heart benefits to its European approval, currently under review by the EU drug regulator, with a decision expected this year.
Viatris generic hypertension drug does not violate J&J patents, US court says: Generic drugmaker Viatris has convinced a federal judge in West Virginia that its ...
reuters.com/legal/litigation/viatris-generic-hypertension-drug-does-not-violate-jj-patents-us-court-says-2024-03-15/
61 Unexpected PFAS ‘Forever Chemicals’ Found in Food Packaging: A global study identified 61 PFAS chemicals in food packaging that are not authorized for use in ...
scientificamerican.com/article/61-unexpected-pfas-forever-chemicals-found-in-food-packaging/
FDA Approves First OTC Continuous Glucose Monitor : The Dexcom Stelo Glucose Biosensor System is for adults with or without diabetes who don't use insulin.
webmd.com/diabetes/news/20240306/cm/fda-approves-first-otc-continuous-glucose-monitor
What Medications Interfere With Birth Control Pills?: Certain medications and birth control pills don’t mix. Some antibiotics, supplements and treatments for HIV ...
health.clevelandclinic.org/medications-that-interfere-with-birth-control
Flu Vaccines to Change After COVID Kills Off One Strain of Virus: An FDA advisory committee has recommended that the United States switch from a quadrivalent to ...
webmd.com/children/vaccines/news/20240306/flu-vaccines-to-change-covid-kills-off-one-strain-virus
London's FTSE 100 opens higher on miners' boost: The UK's FTSE 100 inched higher on Monday as metal miners rose on upbeat economic data from China ...
reuters.com/markets/europe/londons-ftse-100-opens-higher-miners-boost-2024-03-18/
Deadly morel mushroom outbreak highlights big gaps in fungi knowledge: Prized morels are unpredictably and puzzlingly deadly, outbreak report shows.
arstechnica.com/science/2024/03/deadly-morel-mushroom-outbreak-highlights-big-gaps-in-fungi-knowledge/
Ionis Pharma's fatty liver disease drug succeeds in mid-stage trial: Ionis Pharmaceuticals said on Wednesday its experimental drug to treat a type of fatty liver ...
reuters.com/business/healthcare-pharmaceuticals/ionis-pharmas-fatty-liver-disease-drug-succeeds-mid-stage-trial-2024-03-13/
FDA Will Allow Companies to Claim Yogurt Can Cut Diabetes Risk: The FDA will allow yogurt brands to make limited claims that the food can help reduce the risk of ...
healthline.com/health-news/yogurt-can-cut-diabetes-risk
Wockhardt announces success of antibiotic to treat drug-resistant infection: Doctors used Zidebactam/Cefepime to treat a highly drug-resistant skull bone ...
business-standard.com/health/wockhardt-announces-success-of-antibiotic-to-treat-drug-resistant-infection-124031100865_1.html
‘Cruel’: the supreme court could send one-time abortion deserts like Hawaii back in time
theguardian.com/world/2024/mar/24/hawaii-mifepristone-abortion-pill
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics